Exclusive High-Dose Rate Brachytherapy (HDR-BT) for Limited Non-small Cell Lung Carcinoma: Results of a French Study in 199 Patients

Reviewer: Charles Wood, MD
Abramson Cancer Center of the University of Pennsylvania
Ultima Vez Modificado: 19 de octubre del 2005

Translation for this article does not exist

Blogs

The Power of a Cancer Support Group
by Bob Riter
May 26, 2016